INCR Stock Overview
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
InterCure Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪12.25 |
| 52 Week High | ₪13.46 |
| 52 Week Low | ₪3.95 |
| Beta | 0.24 |
| 1 Month Change | 27.64% |
| 3 Month Change | 116.89% |
| 1 Year Change | 37.78% |
| 3 Year Change | -44.27% |
| 5 Year Change | -64.38% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably Well
Feb 16
What InterCure Ltd.'s (TLV:INCR) P/E Is Not Telling You
Sep 19Here's Why InterCure (TLV:INCR) Can Manage Its Debt Responsibly
Aug 22InterCure (TLV:INCR) Seems To Use Debt Quite Sensibly
Feb 14These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably Well
Sep 11What Percentage Of InterCure Ltd (TLV:INCR) Shares Do Insiders Own?
Mar 08Shareholders Are Raving About How The InterCure (TLV:INCR) Share Price Increased 936%
Jan 12Is InterCure (TLV:INCR) Using Debt Sensibly?
Dec 04
Shareholder Returns
| INCR | IL Pharmaceuticals | IL Market | |
|---|---|---|---|
| 7D | 6.7% | 3.5% | 1.5% |
| 1Y | 37.8% | -1.9% | 6.1% |
Return vs Industry: INCR exceeded the IL Pharmaceuticals industry which returned -1.9% over the past year.
Return vs Market: INCR exceeded the IL Market which returned 6.1% over the past year.
Price Volatility
| INCR volatility | |
|---|---|
| INCR Average Weekly Movement | 9.0% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IL Market | 8.2% |
| 10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: INCR's share price has been volatile over the past 3 months.
Volatility Over Time: INCR's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 370 | Alex Rabinovich | www.intercure.co |
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector.
InterCure Ltd. Fundamentals Summary
| INCR fundamental statistics | |
|---|---|
| Market cap | ₪558.27m |
| Earnings (TTM) | -₪61.96m |
| Revenue (TTM) | ₪355.55m |
1.6x
P/S Ratio-9.0x
P/E RatioIs INCR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INCR income statement (TTM) | |
|---|---|
| Revenue | ₪355.55m |
| Cost of Revenue | ₪246.95m |
| Gross Profit | ₪108.60m |
| Other Expenses | ₪170.56m |
| Earnings | -₪61.96m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.36 |
| Gross Margin | 30.54% |
| Net Profit Margin | -17.43% |
| Debt/Equity Ratio | 37.3% |
How did INCR perform over the long term?
See historical performance and comparison